Skip to content

AbbVie ABBV Price / book

Price / book at other companies

Eli Lilly logo
Eli LillyLLY
26.3×-20.7×
Pfizer logo
PfizerPFE
1.8×+0.2×
Johnson & Johnson logo
Johnson & JohnsonJNJ
7.3×+2.1×
Amgen logo
AmgenAMGN
20.6×-6.3×
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
1.5×-0.5×
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
5.9×-1.7×

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$382.49B+3.8%
P/E105.2×+17.4×
P/S6.1×-0.3×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Calculated from AbbVie’s reported figures.

Based on the most recent quarter.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's price / book?
AbbVie (ABBV) reported price / book of 261× in Q1 2025.
How has AbbVie's price / book changed year-over-year?
AbbVie's price / book increased by 548.2% year-over-year, from 40.3× to 261×.
What is the long-term trend for AbbVie's price / book?
Over 4 years (2020 to 2024), AbbVie's price / book has grown at a 59.8% compound annual growth rate (CAGR), from 14.5× to 94.4×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.